http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0043402-A3
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f76c7d857d0f08b76bec4edd71ebf1ad http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d21cbff64022f95c237c0bd3ec8656ca |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-247 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-12 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-12 |
| filingDate | 2000-01-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_491eeb6207d530f7e8dde74247a34f1b |
| publicationDate | 2000-11-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-0043402-A3 |
| titleOfInvention | Inhibitors of intestinal apical membrane na/phosphate co-transportation |
| abstract | The compounds of formula (I) are hydrophilic aryl phosphate, thiophosphate, and aminophosphate intestinal apical membrane Na-mediated phosphate co-transportation inhibitors. The compounds can be administered orally, where they act to inhibit Na-dependent phosphate uptake in the intestines, or internally, where they interact with the phosphate control functions of the kidneys and parathyroid. They are therefore useful for inhibiting sodium-mediated phosphate uptake, reducing serum PTH, calcium, calcitriol, and phosphate, and treating renal disease in an animal, including a human. |
| priorityDate | 1999-01-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 36.